Skip to main content
. 2018 Oct 3;12(1):96–105. doi: 10.1016/j.tranon.2018.09.002

Figure 1.

Figure 1

DDX3 expression in patients with medulloblastoma. A. DDX3 expression in the different molecular subgroup of pediatric and adult medulloblastoma as seen by immunohistochemical staining B. Sample distribution of the different molecular subgroups of medulloblastoma (n = 65) used in our study. C. Kaplan–Meier curve showing overall survival of medulloblastoma patients with low (<2) and high (>2) DDX3 expressing tumors.